BIOLASE, Inc. (BIOL)

NASDAQ: BIOL · IEX Real-Time Price · USD
4.19
-0.16 (-3.57%)
At close: Aug 19, 2022 4:00 PM
4.22
+0.04 (0.84%)
After-hours: Aug 19, 2022 7:18 PM EDT
-3.57%
Market Cap 28.69M
Revenue (ttm) 44.34M
Net Income (ttm) -19.17M
Shares Out 6.85M
EPS (ttm) -2.34
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 87,641
Open 4.44
Previous Close 4.34
Day's Range 4.15 - 4.85
52-Week Range 3.30 - 20.50
Beta 1.49
Analysts Buy
Price Target 20.91 (+399.6%)
Earnings Date Aug 11, 2022

About BIOL

BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, such as cosmetic, restorative, and complex surgical applications. The company offers Waterlase all-tissue dental laser systems for cutting soft and hard tissues; diode soft-tissue laser ... [Read more...]

Industry Health Care Equipment & Supplies
IPO Date Nov 13, 1992
CEO Todd Norbe
Employees 158
Stock Exchange NASDAQ
Ticker Symbol BIOL
Full Company Profile

Financial Performance

In 2021, BIOLASE's revenue was $39.19 million, an increase of 72.03% compared to the previous year's $22.78 million. Losses were -$16.16 million, -3.99% less than in 2020.

Financial Statements

Analyst Forecast

According to 10 analysts, the average rating for BIOL stock is "Buy." The 12-month stock price forecast is 20.91, which is an increase of 399.64% from the latest price.

Price Target
$20.91
(399.64% upside)
Analyst Consensus: Buy
Stock Forecasts

News

BIOLASE DELIVERS 34% REVENUE GROWTH YEAR OVER YEAR IN SECOND QUARTER

LAKE FOREST, Calif. , Aug. 11, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced its financial results for the second quarter ended June 30, 2022.

BIOLASE, Inc to Report Second Quarter 2022 Results on August 11, 2022

LAKE FOREST, Calif. , July 28, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release second quarter 2022 financial and operating res...

BIOLASE EXPANDS INTELLECTUAL PROPERTY PORTFOLIO WITH NEW UNITED STATES AND FOREIGN PATENTS

Company continues to lead the dental laser industry with 302 issued and 31 pending patents LAKE FOREST, Calif. , July 25, 2022 /PRNewswire/ -- BIOLASE , Inc. (NASDAQ: BIOL), the global leader in dental ...

BIOLASE ANNOUNCES TRAINING INITIATIVE WITH EINSTEIN HEALTHCARE NETWORK'S GENERAL DENTISTRY RESIDENCY PROGRAM

LAKE FOREST, Calif. , July 13, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced a pilot program with Einstein Healthcare Network's residency in Gene...

BIOLASE ANNOUNCES PROMOTIONS OF KEY TEAM MEMBERS

LAKE FOREST, Calif., July 7, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today the appointments of Jennifer Bright to Chief Financial Officer ("CFO")...

BIOLASE ANNOUNCES SUPPORT FOR TEAMSMILE PROGRAM

LAKE FOREST, Calif. , July 5, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced a partnership today with TeamSmile.

BIOLASE ENTERS INTO FAVORABLE CREDIT AGREEMENT AMENDMENT

LAKE FOREST, Calif. , June 30, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced that, on June 30, 2022, it entered into an amendment to its senior secured...

BIOLASE Announces Pricing of $6.5 Million Registered Direct Offering Priced At-the-Market

LAKE FOREST, Calif. , June 28, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that it has entered into a securities purchase agreement with a sing...

BIOLASE ANNOUNCES SUPPORT FOR PROJECT HOME

LAKE FOREST, Calif. , June 27, 2022 /PRNewswire/ --  BIOLASE , Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that it has partnered with Project HOME , an organization that pro...

BIOLASE ANNOUNCES ADVANCING DENTISTRY WEBINARS FOR Q3 2022

The industry leading webinar series adds new dates and content for multi-specialty support LAKE FOREST, Calif. , June 21, 2022 /PRNewswire/ -- BIOLASE, Inc.  (NASDAQ: BIOL), the global leader in dental ...

BIOLASE ANNOUNCES ADVANCING DENTISTRY PODCAST

The podcast series includes engaging interviews with leading industry experts, specialists, general dentists and hygienists that share the benefits of laser technology in dentistry LAKE FOREST, Calif. ,...

BIOLASE ANNOUNCES INAUGURAL CLINICAL EXCELLENCE FORUM

Event will focus on optimizing integration of lasers into clinical practice with recognized leaders from all dental specialties and academia FOOTHILL RANCH, Calif. , June 9, 2022 /PRNewswire/ --  BIOLAS...

BIOLASE SIGNS LEASE TO EXPAND TRAINING AND EDUCATION INITIATIVES

LAKE FOREST, Calif. , June 6, 2022 /PRNewswire/ -- To further accelerate the adoption of lasers as the gold standard of care in dentistry, BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental laser...

BIOLASE TO PRESENT AT LD MICRO INVITATIONAL INVESTOR CONFERENCE ON JUNE 8, 2022

LAKE FOREST, Calif. , June 2, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that it will be presenting at the 2022 LD Micro Invitational, a promi...

BIOLASE CREATES FIRST-OF-ITS-KIND CLINICAL INTEGRATION TEAM

Multi-dimensional team of leading specialists, general dentists and hygienists will support the rapid adoption of BIOLASE dental lasers in practices across North America LAKE FOREST, Calif. , June 1, 20...

BIOLASE CEO SHARES VISION FOR KINDLER, GENTLER DENTISTRY WITH CUSTOMERS AROUND THE WORLD

"CEO on the Go" John Beaver visits with customers and future customers, gathering feedback and sharing BIOLASE's commitment to minimally-invasive dentistry for dentists & patients LAKE FOREST, Calif. , ...

BIOLASE TO PARTICIPATE IN THE SPRING INTO ACTION BEST IDEAS VIRTUAL INVESTOR CONFERENCE MAY 17-20, 2022

FOOTHILL RANCH, Calif. , May 16, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it has been invited to present at the Spring Into Action Best...

BIOLASE REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID PRICE REQUIREMENT

FOOTHILL RANCH, Calif. , May 16, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it has received notice from the Nasdaq Stock Market LLC (Nasd...

BIOLASE MAINTAINS GROWTH MOMENTUM AS FIRST QUARTER REVENUE INCREASED 25% YEAR OVER YEAR

LAKE FOREST, Calif. , May 12, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced its financial results for the first quarter ended March 31, 2022.

BIOLASE STRENGTHENS ITS BOARD OF DIRECTORS WITH ADDITION OF SEASONED HEALTHCARE EXECUTIVE

FOOTHILL RANCH, Calif. , May 9, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that Kenneth P.

BIOLASE, Inc to Report First Quarter 2022 Results on May 12, 2022

FOOTHILL RANCH, Calif. , May 4, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release first quarter 2022 financial and operating res...

BIOLASE ANNOUNCES 1-FOR-25 REVERSE STOCK SPLIT

COMMON STOCK WILL BEGIN TRADING ON SPLIT-ADJUSTED BASIS ON APRIL 29, 2022 LAKE FOREST, Calif., April 28, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), today announced t...

BIOLASE TO PARTICIPATE IN MAXIM GROUP'S 2022 VIRTUAL GROWTH CONFERENCE HOSTED BY M-VEST ON MARCH 28TH - 30TH

FOOTHILL RANCH, Calif. , March 23, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that President and CEO, John Beaver, has been invited to partici...

BIOLASE REPORTS CONTINUED GROWTH FOR FOURTH QUARTER AND FULL YEAR 2021

Robust Balance Sheet to Execute Growth Strategies in 2022 Full Year 2022 Revenue Growth Outlook +10% LAKE FOREST, Calif., March 17, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader i...

BIOLASE to Report Fourth Quarter and Full Year 2021 Results on March 17, 2022

FOOTHILL RANCH, Calif. , March 3, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release fourth quarter and full-year 2021 financial ...